Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

June 01, 2023; Volume 51,Issue 6

Special Section on Perspective on Drug Metabolism and Disposition, Part I

50th Anniversary Celebration Collection

  • You have access
    Special Section on Perspectives on Drug Metabolism and Disposition, Part I—Editorial
    Yurong Lai and Xinxin Ding
    Drug Metabolism and Disposition June 2023, 51 (6) 645-646; DOI: https://doi.org/10.1124/dmd.123.001352
  • You have access
    Human Absorption, Distribution, Metabolism, and Excretion Studies: Origins, Innovations, and Importance
    Matthew A. Cerny, Douglas K. Spracklin and R. Scott Obach
    Drug Metabolism and Disposition June 2023, 51 (6) 647-656; DOI: https://doi.org/10.1124/dmd.122.001006
  • You have access
    Fifty Years of Aryl Hydrocarbon Receptor Research as Reflected in the Pages of Drug Metabolism and Disposition
    David S. Riddick
    Drug Metabolism and Disposition June 2023, 51 (6) 657-671; DOI: https://doi.org/10.1124/dmd.122.001009
  • Epigenetic Mechanisms Contribute to Intraindividual Variations of Drug Metabolism Mediated by Cytochrome P450 Enzymes
    You have access
    Epigenetic Mechanisms Contribute to Intraindividual Variations of Drug Metabolism Mediated by Cytochrome P450 Enzymes
    Jing Jin and Xiao-bo Zhong
    Drug Metabolism and Disposition June 2023, 51 (6) 672-684; DOI: https://doi.org/10.1124/dmd.122.001007
  • Open Access
    Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research
    Joseph M. Cronin and Ai-Ming Yu
    Drug Metabolism and Disposition June 2023, 51 (6) 685-699; DOI: https://doi.org/10.1124/dmd.122.001008
  • Open Access
    Impact of Intracellular Lipid Binding Proteins on Endogenous and Xenobiotic Ligand Metabolism and Disposition
    King Clyde B. Yabut and Nina Isoherranen
    Drug Metabolism and Disposition June 2023, 51 (6) 700-717; DOI: https://doi.org/10.1124/dmd.122.001010

Minireview

50th Anniversary Celebration Collection

  • You have access
    Combined Oral Contraceptives As Victims of Drug Interactions
    Li Li, Xinning Yang, Doanh Tran, Shirley K. Seo and Yanhui Lu
    Drug Metabolism and Disposition June 2023, 51 (6) 718-732; DOI: https://doi.org/10.1124/dmd.122.000854

Articles

  • You have access
    Characterization of Enzymes Involved in Nintedanib Metabolism in Humans
    Shimon Nakashima, Rei Sato, Tatsuki Fukami, Takashi Kudo, Shiori Hashiba, Gaku Morinaga, Masataka Nakano, Eva Ludwig-Schwellinger, Akiko Matsui, Naoki Ishiguro, Thomas Ebner and Miki Nakajima
    Drug Metabolism and Disposition June 2023, 51 (6) 733-742; DOI: https://doi.org/10.1124/dmd.122.001113
  • You have access
    A Physiologically-Based Pharmacokinetic Model for Cannabidiol in Healthy Adults, Hepatically-Impaired Adults, and Children
    Sumit Bansal, Mayur K. Ladumor, Mary F. Paine and Jashvant D. Unadkat
    Drug Metabolism and Disposition June 2023, 51 (6) 743-752; DOI: https://doi.org/10.1124/dmd.122.001128
  • Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
    You have access
    Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
    William L. Fitch, Steven Smith, Michael Saporito, Gregory Busse, Mingbao Zhang, Julie Ren, Michael E. Fitzsimmons, Ping Yi, Stephen English, Adam Carter and Thomas A. Baillie
    Drug Metabolism and Disposition June 2023, 51 (6) 753-763; DOI: https://doi.org/10.1124/dmd.122.001218
  • Open Access
    Inactivation of Human Aldehyde Oxidase by Small Sulfhydryl-Containing Reducing Agents
    Mariam Esmaeeli, Manfred Nimtz, Lothar Jänsch, Lloyd W. Ruddock and Silke Leimkühler
    Drug Metabolism and Disposition June 2023, 51 (6) 764-770; DOI: https://doi.org/10.1124/dmd.122.001244
  • Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
    You have access
    Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
    Xiang Chen, Luyao Han, Yulin Zhao, Haoyan Huang, He Pan, Chenmeng Zhang, Huili Chen, Shanliang Sun, Sihui Yao, Xijing Chen and Yongjie Zhang
    Drug Metabolism and Disposition June 2023, 51 (6) 771-781; DOI: https://doi.org/10.1124/dmd.122.001245
  • You have access
    Mechanistic Investigation of the Time-Dependent Aldehyde Oxidase Inhibitor Hydralazine
    J. Paige Barnes, Shaoyun M. Yang, Taylor S. Thompson, Caithlyne M. Guevarra, Shaniya S. Pleasant, Tri Q. Do and Rachel D. Crouch
    Drug Metabolism and Disposition June 2023, 51 (6) 782-791; DOI: https://doi.org/10.1124/dmd.123.001257
Back to top
Previous

In this issue

Drug Metabolism and Disposition: 51 (6)
Drug Metabolism and Disposition
Vol. 51, Issue 6
1 Jun 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Special Section on Perspective on Drug Metabolism and Disposition, Part I

    50th Anniversary Celebration Collection
  • Minireview

    50th Anniversary Celebration Collection
  • Articles
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics